Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer
Lorenzo Castagnoli(Fondazione IRCCS Istituto Nazionale dei Tumori), Serenella M. Pupa(Tumori Foundation)
Cited by 21
Related Papers
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
|Oncogene|2019|185
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)
|International Journal of Cancer|2018|65
CD36 enrichment in HER2-positive mesenchymal stem cells drives therapy refractoriness in breast cancer
|Journal of Experimental & Clinical Cancer Research|2025|11